Advertisement

 

 

Autoantibodies to heterogeneous nuclear ribonuclear protein A1 (hnRNPA1) cause altered ‘ribostasis’ and neurodegeneration; the legacy of HAM/TSP as a model of progressive multiple sclerosis.

Autoantibodies to heterogeneous nuclear ribonuclear protein A1 (hnRNPA1) cause altered ‘ribostasis’ and neurodegeneration; the legacy of HAM/TSP as a model of progressive multiple sclerosis.
Author Information (click to view)

Levin MC, Lee S, Gardner LA, Shin Y, Douglas JN, Salapa H,


Levin MC, Lee S, Gardner LA, Shin Y, Douglas JN, Salapa H, (click to view)

Levin MC, Lee S, Gardner LA, Shin Y, Douglas JN, Salapa H,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

Journal of neuroimmunology 2016 07 17304() 56-62 pii 10.1016/j.jneuroim.2016.07.005

Abstract

Several years following its discovery in 1980, infection with human T-lymphotropic virus type 1 (HTLV-1) was shown to cause HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP), a disease biologically similar to progressive forms of multiple sclerosis (MS). In this manuscript, we review some of the clinical, pathological, and immunological similarities between HAM/TSP and MS with an emphasis on how autoantibodies to an RNA binding protein, heterogeneous nuclear ribonuclear protein A1 (hnRNP A1), might contribute to neurodegeneration in immune mediated diseases of the central nervous system.

Submit a Comment

Your email address will not be published. Required fields are marked *

1 × 4 =

[ HIDE/SHOW ]